QKF-10984-04753
2 vaccinations
4 coded responses
14 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 296 / SC
- Registered
- 2021-08-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-18
Dose 1 — Pfizer-BioNTech
-
2021-08-16
Dose 2 — Pfizer-BioNTech
-
2021-08-17
Registered in v-safe
-
2021-08-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-08-18
- 2021-08-20
- 2021-08-21
- 2021-08-22
- 2021-08-23
- 2021-08-30
- 2021-09-08
- 2021-09-13
- 2021-09-22
-
2021-09-27
Survey response — day 42, dose 2MedDRA: Headache, Respiratory tract congestion — Feeling: FairFree text: Congestion, headacheMedDRA releases: 2024-11 · check-in free text available
-
2021-11-15
Survey response — 3 months, dose 2MedDRA: Herpes zoster — Feeling: Fair · Be unable to work or attend schoolFree text: ShinglesMedDRA releases: 2024-11 · check-in free text available
-
2022-02-14
Survey response — 6 months, dose 2MedDRA: Cough, Nasopharyngitis, Oropharyngeal pain, Respiratory tract congestion — Feeling: Good · Be unable to do your normal daily activitiesFree text: Head cold symptoms- congestion, tonsil pain, coughMedDRA releases: 2024-11 · check-in free text available
-
2022-08-16
Survey response — 12 months, dose 2MedDRA: Pneumonia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: PneumoniaMedDRA releases: 2024-11 · check-in free text available
-
2022-08-16
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-08-17
- 2022-08-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-18 | Pfizer-BioNTech | No |
| 2 | 2021-08-16 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 9 — day 42, dose 2
Symptoms: Congestion, headache
Release 10 — 3 months, dose 2
Symptoms: Shingles
Release 11 — 6 months, dose 2
Symptoms: Head cold symptoms- congestion, tonsil pain, cough
Release 12 — 12 months, dose 2
Symptoms: Pneumonia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Herpes zoster | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pneumonia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release